baber/WOPTO huggingface dataset:
Patent PT-1809897-E (PT)
Title: Apparatus for converting wave energy into electric power
Inventor: CLEMENT ALAIN
IPC: F03B13/20
Filed: 2005-10-13
Abstract: The invention concerns an apparatus for converting wave energy into electric power, comprising a closed floating element (1) and a mass forming element (2), the mass forming element (2) being arranged inside the floating element (1) and mounted mobile relative to the floating element (1), the mass forming element (2) being adapted to be set in relative motion with respect to the floating element (1) under the action of the waves on the floating element (1). The invention is characterized in that it also comprises locking means (13) adapted to lock the movement of the mass forming element (2) and control means adapted to control the locking means (13) for selectively locking or releasing the mass element (2) so as to amplify the movement of the mass forming element (2) by constant adaptation to the dynamics of the apparatus to successive waves.
Patent PT-1858930-E (PT)
Title: Process for the preparation of trivalent iron complexes with mono-, di- and polysaccharide sugars
Inventor: MARCHI EGIDIO
IPC: A61K31/70
Filed: 2006-03-14
Abstract: Process for the preparation of trivalent iron complexes with mono-, di- and polysaccharide sugars, consisting of the activation of the sugar by oxidation with nascent bromine generated in situ by reaction between an alkaline or alkaline earth bromine and an alkaline hypochlorite, the complexation of the activated sugar in solution with a ferric salt dissolved in an aqueous solution, the purification of the resulting solution through ultrafiltration and finally the stabilization of the trivalent iron-sugar complex by heating at a temperature between 60° C. and 100° C. for a period between 1 and 4 hours at a pH between 9.0 and 11.0.
Patent PT-1988924-E (PT)
Title: New stable hyperbaric composition comprising prilocaine hcl, use of said new composition for intrathecal anaesthesia, and method for manufacturing said composition
Inventor: MITIDIERI AUGUSTO
IPC: A61P23/02
Filed: 2007-02-14
Abstract: The present invention concerns new preservative-free hyperbaric compositions of prilocaine HCI intended for use in intrathecal narcosis, characterized by high stability at ambient temperature (15° C. -27° C.). The present invention also concerns a method for manufacturing said compositions.
Patent PT-2066349-E (PT)
Title: Humanized anti-cd19 antibodies and their use in treatment of tumors, transplantation and autoimmune diseases
Inventor: DAMSCHRODER MELISSA
IPC: A61K39/395
Filed: 2007-09-07
Abstract: The present invention provides chimeric and humanized versions of anti-CD19 mouse monoclonal antibodies. The invention further relates to pharmaceutical compositions, immunotherapeutic compositions, and methods using therapeutic antibodies that bind to the human CD19 antigen and that may mediate ADCC, CDC, and/or apoptosis for the treatment of B cell diseases and disorders, such as, but not limited to, B cell malignancies, for the treatment and prevention of autoimmune disease, and for the treatment and prevention of graft-versus-host disease (GVHD), humoral rejection, and post-transplantation lymphoproliferative disorder in human transplant recipients.
Patent PT-2067790-E (PT)
Title: Agonist antibody against protein tyrosine kinase sal-s1
Inventor: MATTHEWS WILLIAM
IPC: C12Q1/6876
Filed: 1995-04-04
Abstract: Agonist antibody is disclosed which binds to the extracellular domain of receptor protein tyrosine kinase pTK, and thereby cause dimerization and activation of the intracellular tyrosine kinase domain thereof. The antibody is useful for activating its respective receptor and thereby enabling the role of the tyrosine kinase receptor in cell growth and/or differentiation to be studied. Chimeric proteins comprising the extracellular domain of the receptor pTKs and an immunoglobulin constant domain sequence are also disclosed.
Patent PT-2090050-E (PT)
Title: Method and apparatus of establishing a synchronisation signal in a communication system
Inventor: POPOVIC BRANISLAV M
IPC: H04L27/26
Filed: 2008-04-29
Abstract: A method of establishing a synchronization signal in a communication system is disclosed. A set of discrete Fourier frequency coefficients is defined and transformed into a discrete time representation, the discrete time representation being particularly useful as a synchronization signal. According to example embodiments of the invention, signal symmetry is exploited. Preferably, the center frequency, also referred to as DC subcarrier, is not used for transmission. The invention also concerns a transmitter and receiver of a communication system.
Patent PT-2117818-E (PT)
Title: Fibre application machine with flexible fibre supply tubes
Inventor: HAMLYN ALEXANDER
IPC: B29C70/38
Filed: 2008-02-21
Abstract: A fiber application machine, for making components out of composite materials, that includes a system for displacing a fiber application head, fiber storage means, and fiber conveying means for conveying fibers from said storage means to the application head. The conveying means include flexible tubes connecting the storage means to the application head, each flexible tube being fitted with at least one longitudinal flexible blade of rectangular transverse cross-section, said flexible blade being placed substantially parallel to the plane of transport of the fiber received in the inner passage of the flexible tube.
Patent PT-2203431-E (PT)
Title: Anti-infective pyrimidines and uses thereof
Inventor: HAIGHT ANTHONY R
IPC: A61K31/513
Filed: 2008-09-17
Abstract: The present invention relates to a crystalline form of N-(6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide or a crystalline form of a salt of N-(6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide as well as pharmaceutical compositions comprising said crystalline forms, therapeutic uses of said crystalline forms and processes for making said crystalline forms.
Patent PT-2149644-E (PT)
Title: Drain valve for a cistern
Inventor: WESSEL HEINZ-WERNER
IPC: E03D1/14
Filed: 2009-04-30
Abstract: The valve (1) has a housing (3) provided with a valve seat (5) that defines a discharge opening (4). An overflow tube (6) comprises of upper parts and lower parts (6b) and is movably supported along a longitudinal axis (X) in the housing. The tube is provided with a seal (7) i.e seal disk, that co-acts with the valve seat at a lower end. The housing has an upper housing part (3a) and a lower housing part (3b), which are connected together in a swivelable manner via one of joint connections (8, 10). The valve seat is swivelable relative to the upper housing part and/or the overflow tube. An independent claim is also included for a cistern comprising an inspection opening.
Patent PT-2168948-E (PT)
Title: 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors
Inventor: BOLD GUIDO
IPC: A61P35/00
Filed: 2001-01-25
Abstract: The invention relates to the use of 2-amino-nicotinamide derivatives of formula I   
wherein n is from 1 up to and including 6; 
W is O or S; 
R 1  and R 3  represent independently of each other hydrogen, lower alkyl or lower acyl; 
R 2  represents a cycloalkyl group, an aryl group, or a mono- or bicyclic heteroaryl group comprising one or more ring nitrogen atoms and 0, 1 or 2 heteroatoms independently from each other selected from the group consisting of oxygen and sulfur, which groups in each case are unsubstituted or mono- or polysubstituted; 
R and R' are independently of each other hydrogen or lower alkyl; 
X represents an aryl group, or a mono- or bicyclic heteroaryl group comprising one or more ring nitrogen atoms and 0, 1 or 2 heteroatoms independently from each other selected from the group consisting of oxygen and sulfur, which groups in each case are unsubstituted or mono- or polysubstituted; 
or a N-oxide, a possible tautomer thereof or a pharmaceutically acceptable salt of such a compound, 
alone or in combination with one or more other pharmaceutically active compounds for the preparation of a pharmaceutical composition for use for therapy of a disease which responds to an inhibition of the VEGF-receptor tyrosine kinase activity; 
and to new 2-amino-nicotinamide derivatives of formula I and processes for the preparation thereof.
Patent PT-2360849-E (PT)
Title: Method and apparatus for sequence distribution and processing in a communication system
IPC: H04L23/02
Filed: 2007-09-25
Abstract: A sequence distributing and sequence processing method and apparatus in a communication system are provided. The sequence distributing method includes the following steps of: generating sequence groups comprising a number of sequences, the sequences in the sequence groups are determined according to the sequence time frequency resource occupation manner which is supported by the system; distributing the sequence groups to cells. The method avoids the phenomenon that signaling transmission is needed to distribute the sequences to the cells for different time frequency resource occupation manner, and saves in so far as possible the wireless network transmission resource occupied during the process of distributing the sequences through distributing the sequence groups comprising a number of sequences to the cells.
Patent PT-672115-E (PT)
Inventor: BAILEY FRED J
IPC: C12P19/04
Filed: 1993-10-06
Abstract: A culture medium containing no complex animal components is useful for production of bacteria and inoculum development from which pharmaceutically important products are to be isolated.
Patent PT-742791-E (PT)
Inventor: FARR ROBERT A
IPC: C12N9/99
Filed: 1994-11-28
Abstract: PCT No. PCT/US94/13711 Sec. 371 Date Sep. 9, 1996 Sec. 102(e) Date Sep. 9, 1996 PCT Filed Nov. 28, 1994 PCT Pub. No. WO95/21186 PCT Pub. Date Aug. 10, 1995The present invention provides novel macrocyclic difluorostatone derivatives which are useful as antiviral agents. More specifically, these novel compounds are useful as inhibitors of retroviral proteases required for replication, particularly the HIV-1 and HIV-2 viral proteases, in the prevention or treatment of infection by the human immunodeficiency virus (HIV), and in the treatment of consequent pathological conditions such as the acquired immunodeficiency syndrome (AIDS) in mammals capable of being infected with HIV virus.
Patent PT-814836-E (PT)
Inventor: HILGERS LUUK
IPC: A61K39/39
Filed: 1995-12-21
Abstract: Vaccine adjuvants comprising a sulpholipid polysaccharide in combination with an interface-forming constituent. The invention also provides a method for preparing a vaccine by emulsifying an aqueous solution of an antigen and a sulpholipid polysaccharide. The adjuvants are stable at high temperatures, and are at least as effective as conventional adjuvants. Their local toxicity, i.e. their reactogenicity, is generally lower than that of conventional adjuvants.
Patent PT-831987-E (PT)
Inventor: TUNIS GEORGE C
IPC: B29C33/00
Filed: 1996-06-04
Abstract: Large composite structures are produced using a vacuum assisted resin transfer molding process incorporating a resin distribution network. The resin distribution network is provided by a textured sheet (104) of metal formed as an integral vacuum bag and mold. The texture is formed by upraised portions (108) on one side of the sheet which correspond with depressions on the other side. Valleys between the upraised portions form the resin distribution network. A fiber lay up is placed against the textured sheet (104) with the upraised portions facing the lay up. Main feeder grooves (114) are also formed directly in the sheet (104). Resin is supplied under vacuum to the main feeder grooves, from where it travels through the valleys of the textured sheet (104) to impregnate the lay up. <IMAGE>
Patent PT-954282-E (PT)
Inventor: LANGER ROBERT S
IPC: A61K47/48
Filed: 1997-11-17
Abstract: Particles incorporating a surfactant and/or a hydrophilic or hydrophobic complex of a positively or negatively charged therapeutic agent and a charged molecule of opposite charge for drug delivery to the pulmonary system, and methods for their synthesis and administration are provided. In a preferred embodiment, the particles are made of a biodegradable material and have a tap density less than 0.4 g/cm<3> and a mass mean diameter between 5  mu m and 30  mu m, which together yield an aerodynamic diameter of the particles of between approximately one and three microns. The particles may be formed of biodegradable materials such as biodegradable polymers. For example, the particles may be formed of poly(lactic acid) or poly(glycolic acid) or copolymers thereof. Alternatively, the particles may be formed solely of a therapeutic or diagnostic agent and a surfactant. Surfactants can be incorporated on the particule surface for example by coating the particle after particle formation, or by incorporating the surfactant in the material forming the particle prior to formation of the particle. Exemplary surfactants include phosphoglycerides such as dipalmitoyl phosphatidylcholine (DPPC). The particles can be effectively aerosolized for administration to the respiratory tract to permit systemic or local delivery of wide a variety of therapeutic agents. Formation of complexes of positively or negatively charged therapeutic agents with molecules of opposite charge can allow control of the release rate of the agents into the blood stream following administration.
Patent PT-979329-E (PT)
Inventor: EICHER BERNHARD
IPC: B21J15/02
Filed: 1999-02-02
Abstract: A wire netting, preferably used as a gravel screen or for protecting a soil surface layer is woven from corrosion-resistant wires and either fitted on the soil surface or secured in an almost upright position on a slope or something similar. The wires in the wire netting are manufactured from heavy-duty steel, which has a nominal strength in the region of 1000 to 2200 N/mm2 and steel wire may be used for this for stranded wires or spring steel wire. The wire netting is manufactured from rectangular, diagonal netting and it has a three-dimensional, mattress-like structure.
Patent PT-1117463-E (PT)
Inventor: PROCIDA JAN
IPC: C08F8/12
Filed: 1999-10-01
Abstract: Halogenous, organic waste material such as PVC is subjected to a hydrolysis treatment by suspending 1 part by weight of the waste material in comminuted state in 1-10 parts by weight of water in the presence of a base and heating this to a temperature of between 250-280° C. at a pressure sufficient to maintain the water in liquid state for a period of time sufficient to convert substantially all organically bound halogen present to inorganic halides. By the treatment valuable halogen-free organic compounds are generated as decomposition products ensuring the economy of the treatment.
Patent SG-3888-G (SG)
Title: Information recording and/or reading system
IPC: G11B17/02
Filed: 1988-01-08
Abstract: An interchangeable disc unit comprises a disc pack (6) which is accommodated in a square enclosure comprising two covers (9, 10) which can move relative to each other from a closed position and which are interconnected by separate connecting means (29) in said closed position, which connecting means are situated near the corners of the covers. (9, 10) Each of the connecting means (29) comprises a plurality of elastically pivotable fingers, (41) which extend away from the one cover (9), and which elastically press against an annular stop (40) on the other cover (10) in the closed position.
Patent IE-34970-L (IE)
Title: Phenylethanolamine derivatives
IPC: C07C215/00
Filed: 1971-02-25
Abstract: 1340407 Phenylethanolamine derivatives BOEHRINGER INGELHEIM GmbH 19 April 1971 [25 Feb 1970] 22455/71 Heading C2C Compounds of the general formula (A = phenyl or substituted phenyl group, or condensed bicyclic group wherein the ring not directly bonded to the chain is carbocyclic or heterocyclic and saturated or aromatic; R 1 = H, alkyl, alkoxy; R 2 = H, Me, Et; R 3 = H, Me; R 4 = H, alkyl; R 5 = H, OH) and their salts are prepared by (a) removing the protecting group(s) in a compound of the formula (R 6,7 = H, protecting group (not both H)) or (b) reducing a compound of the formula (B = CO, CHOH), optionally followed in either case by isomer separation and/or salt formation. The preparation of starting materials for processes (a) and (b) by standard methods is described. The above compounds are of interest in the treatment of cardiac insufficiency and for stabilizing the circulation. They may be administered in the form of pharmaceutical preparations containing them in association with a carrier.
[GB1340407A]
Patent IE-32020-L (IE)
Title: Sanitary disposal units
IPC: B65F7/00
Filed: 1968-04-17
Abstract: 1,180,478. Sanitary disposal units. CANNON HYGIENIC PRODUCTS Ltd. 16 April, 1968 [21 April, 1967], No. 18560/67. Heading A4A. A disposable sanitary disposal unit comprises a water-tight receptacle 1 for the reception of waste material, an inlet into and means for closing the receptacle comprising an open-ended sleeve 6 depending within the receptacle and which has co-axially and slideably located within it a sleeve-like liner 7 open at its lower end 8 and closed at its upper end by a plate 9 which closes the receptacle when the liner is in its lowermost position and having an aperture 11 so that when the liner is raised the waste material may be inserted through the aperture, and means for introducing a germicidal or similar product into the receptacle. Said means may comprise a flexible bag 13 containing the germicidal or other product 14 suspended in the receptacle by a cord 15 ending in a loop 17 outside the receptacle, a pull on the loop 17 severing the neck 16 of the bag. Further means for introducing a germicidal product comprises an inverted flexible bottle 17, which also acts as a handle for the liner 7, pressure on the bottle ejecting fluid from a nozzle 22 or tube (not shown), the tube being positioned with respect to the aperture 11 so that the introduction of waste material pushing the tube allows liquid to flow from the bottle into the receptacle.
[GB1180478A]
Patent IE-44784-L (IE)
Title: Prepacked kaolin poultice dressing
IPC: A61J3/00
Filed: 1977-03-08
Abstract: 1512741 Kaolin poultices K/L (PHARMACEUTICAL) Ltd 8 March 1977 [13 March 1976] 10136/76 Heading A5R [Also in Division B8] A prepacked kaolin poultice dressing comprises a predetermined quantity of kaolin 7 sandwiched between a metallic foil 2 and a heat sealable film material I, and a coating 14 of biologically inert lubricant being interposed between the kaolin and the heat sealable film material to provide for easy separation of the film material from the kaolin, the metallic foil and the film material being heat sealed adjacent the perimeter of the kaolin. The heat sealable film material and the metallic foil are first heat sealed together around three sides and the kaolin is then extruded from a filling machine through a nozzle having an elongated opening, coated on one side with lubricant, such as petroleum jelly, and filled into the pouch formed by the sealed sheets, the fourth side of the pouch then being sealed. The lubricant may be held on one of the flattened surfaces of the nozzle and is then deposited as a layer on the film material as the nozzle is inserted into the pouch, the lubricant being renewed on the nozzle thereafter. Alternatively the kaolin may be extruded onto the metallic foil, the exposed kaolin surface coated with lubricant and the film material then superimposed and heat-sealed. The film material may be metallic foil or a polyester.
[GB1512741A]
Patent IE-870535-L (IE)
Title: Human endothelial cell growth factor
IPC: C12N15/09
Filed: 1987-03-03
Abstract: Endothelial cell growth factor is achieved through the application of recombinant DNA technology to prepare cloning vehicles encoding the ECGF protein and procedures are disclosed for recovering ECGF protein essentially free of other proteins of human origin. The product is useful for, among other purposes, diagnostic applications and as potential in the treatment of damaged blood vessels or other endothelial cell-line structures.
Patent IE-40913-L (IE)
Title: Amides
IPC: C07C231/00
Filed: 1975-04-08
Abstract: New acylanilides of the formula <IMAGE> (I) wherein R1 represents alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or halogen, R2 represents hydrogen, alkyl of 1 to 3 carbon atoms, alkoxy of 1 to 4 carbon atoms or halogen, R7 represents hydrogen, alkyl of 1 to 3 carbon atoms, alkoxy of 1 to 4 carbon atoms or halogen, R8 represents hydrogen or methyl, the total number of carbon atoms of the substituents R1, R2, R7 and R8 in the phenyl ring not exceeding 8, X represents <IMAGE> wherein each of R', R'' and R''' independently represents hydrogen, methyl, or ethyl, and Y represents one of the following groups: <IMAGE> (a) wherein Hal is a halogen anion, (b) -O-R4, (c) -S-R4, wherein R4 represents alkyl of 1 to 6 carbon atoms, alkenyl of 3 to 6 carbon atoms, alkynyl of 3 to 6 carbon atoms, each of them unsubstituted or substituted by a halogen atom, or R4 represents benzyl of phenyl which independently may be unsubstituted or substituted by halogen or alkyl of 1 to 4 carbon atoms or <IMAGE> (d) wherein each of R5 and R6 independently represents alkyl of 1 to 4 carbon atoms are disclosed which act as microbicides. They may preferably be used for combating phytopathogenic fungi.
[US4294850A]
Patent FI-811349-L (FI)
Inventor: PETROV ALEXANDER SIMEONOV
IPC: B30B1/02
Filed: 1981-04-29
Abstract: A pressworking operation on a workpiece or material which enables pressworking energy to be transmitted to the workpiece or material in a plurality of steps with there being no sudden increase in the coefficient of friction between the working tool and the workpiece or material after release of accumulated potential energy from an elastically deformable energy carrier and in which the velocity of displacement of the working tool does not change sign until completion of working of the workpiece or material is made possible by use of a press apparatus comprising a power cam (2) contacting a roll (1) attached to a quaternary lever (3) at one connection point of the lever, the quaternary lever being connected at a second hinged connection point (6) to a rigid support at a third connection point (4) to the elastically deformable member (9) connected in turn to a second rigid support (21), with the quaternary lever being connected at its fourth connection point (7) through a hinged connecting rod (10, 13) to a unit (14, 18) carrying a part (19) of a working tool and capable of reciprocating movement. The cam (2) includes sections for enabling energy to be accumulated in the elastically deformable member (9) and for release of the energy therefrom over a shorter time period than the energy accumulating time period through the medium of the quaternary lever (3) operating as a functional force-varying member. The apparatus includes provision for effecting powered variation of the angle between the semirods (10, 13) independently of displacement which may be imparted to the unit (14, 18).
Patent FI-853514-L (FI)
Inventor: BJOERKENGREN CARL-AXEL
IPC: B29C53/50
Filed: 1985-09-13
Abstract: 57 A packaging tube of the laminate type having dead-fold characteristics, comprising a body of a metal foil containing laminate and a tube breast arranged at one end of the body, and an elongated strip of a metal foil containing laminate attached to the tube body and extending generally along the entire length thereof.The metal contents of the strip provides dead-fold and the thickness of the metal foil of the tube body falls within the interval 5 to 40 microns and is selected such that it is considerably thinner than the thickness of the metal foil of the strip which falls within the interval 40 to 200 microns.Such arrangement allows a minimum of metal foil thickness in the tube body, meaning that the body foil thickness basically may be maintained at a gas and vapor barrier level.The tube body has a longitudinal joint covered by said strip generally along the entire length thereof.